Sonography-guided Resection of Brain Mass Lesions
Launched by SKLIFOSOVSKY INSTITUTE OF EMERGENCY CARE · Jul 29, 2022
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring the use of ultrasound during brain surgery to help identify and remove different types of brain masses, such as tumors, arteriovenous malformations (which are abnormal connections between blood vessels), cavernomas (a type of blood vessel malformation), and bleeding in the brain. The goal is to see how effective ultrasound can be in guiding surgeons during these procedures and determining the best way to use ultrasound tools during surgery.
To participate in this trial, you must be between 18 and 100 years old and have a newly diagnosed brain issue that falls into one of the categories mentioned. Participants should be in stable health and not have had previous brain radiation therapy. If you join the study, you can expect to undergo surgery where ultrasound will be used to help the doctors during the procedure. This research aims to improve surgical outcomes and enhance the safety of brain surgeries using advanced imaging techniques.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • all intracranial tumors
- • cavernomas
- • arteriovenous malformations
- • spontaneous (non-traumatic) intracerebral hemorrhages
- • traumatic intracerebral hemorrhages
- • supratentorial localization
- • newly diagnosed
- • age 18-100 years
- • stable hemodynamics
- Exclusion Criteria:
- • rapid cerebral dislocation
- • previously performed brain radiotherapy
About Sklifosovsky Institute Of Emergency Care
The Sklifosovsky Institute of Emergency Care is a leading clinical research organization dedicated to advancing emergency medicine through innovative research and development. Renowned for its expertise in urgent medical interventions, the institute conducts rigorous clinical trials aimed at improving patient outcomes and enhancing treatment protocols. With a multidisciplinary team of experienced healthcare professionals, researchers, and clinicians, the Sklifosovsky Institute is committed to fostering collaboration and utilizing cutting-edge methodologies to address critical healthcare challenges in emergency settings. Its focus on evidence-based practices ensures that findings contribute significantly to the global body of knowledge in emergency care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Moscow, , Russian Federation
Patients applied
Trial Officials
Alexander Dmitriev, MD
Principal Investigator
Sklifosovsky Institute of Emergency Care
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials